POCT Market in Europe 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	162 Pages	TechNavio	July, 2023	INF18150551

Best Price Guarantee
Price	from $2,500
Length	162 Pages
Publisher	TechNavio
Published Date	July, 2023
SKU	INF18150551

POCT Market In Europe 2023-2027

The POCT market in Europe is forecasted to grow by USD 5750.84 mn during 2022-2027, accelerating at a CAGR of 7.75% during the forecast period. The report on the POCT market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in healthcare industry.

Technavio's POCT market in Europe is segmented as below:

By Type

OTC testing
Prescription-based testing

By Application

Blood glucose testing
Infectious diseases testing
Cardiac markers testing
Pregnancy and fertility testing
Others

By Geographical Landscape

Europe

This study identifies the shift from conventional testing methods to rapid diagnostic test as one of the prime reasons driving the POCT market in Europe growth during the next few years. Also, technological advances in diagnostics and increasing focus on introducing low-cost test strips will lead to sizable demand in the market.

The report on the POCT market in Europe covers the following areas:

POCT market sizing in Europe
POCT market forecast in Europe
POCT market industry analysis in Europe

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POCT market in Europe vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the POCT market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by Application; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
4 Historic Market Size: 4.1 POCT market in Europe 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million); 4.2 Type Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million); 4.3 Application Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 22: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 25: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 26: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 27: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 28: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 29: Chart on Type - Market share 2022-2027 (%); Exhibit 30: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 31: Chart on Comparison by Type; Exhibit 32: Data Table on Comparison by Type; 6.3 OTC testing - Market size and forecast 2022-2027; Exhibit 33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million); Exhibit 34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million); Exhibit 35: Chart on OTC testing - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%); 6.4 Prescription-based testing - Market size and forecast 2022-2027; Exhibit 37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million); Exhibit 38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million); Exhibit 39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibit 40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Type; Exhibit 41: Market opportunity by Type ($ million); Exhibit 42: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Exhibit 43: Chart on Application - Market share 2022-2027 (%); Exhibit 44: Data Table on Application - Market share 2022-2027 (%); 7.2 Comparison by Application; Exhibit 45: Chart on Comparison by Application; Exhibit 46: Data Table on Comparison by Application; 7.3 Blood glucose testing - Market size and forecast 2022-2027; Exhibit 47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million); Exhibit 48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million); Exhibit 49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%); 7.4 Infectious diseases testing - Market size and forecast 2022-2027; Exhibit 51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million); Exhibit 52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million); Exhibit 53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%); 7.5 Cardiac markers testing - Market size and forecast 2022-2027; Exhibit 55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million); Exhibit 56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million); Exhibit 57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibit 58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%); 7.6 Pregnancy and fertility testing - Market size and forecast 2022-2027; Exhibit 59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million); Exhibit 60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million); Exhibit 61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibit 62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); 7.7 Others - Market size and forecast 2022-2027; Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%); 7.8 Market opportunity by Application; Exhibit 67: Market opportunity by Application ($ million); Exhibit 68: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 70: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibit 71: Data Table on Market share By Geographical Landscape - 2022-2027 (%); 9.2 Geographic comparison; Exhibit 72: Chart on Geographic comparison; Exhibit 73: Data Table on Geographic comparison; 9.3 Germany - Market size and forecast 2022-2027; Exhibit 74: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 75: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 76: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 77: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.4 France - Market size and forecast 2022-2027; Exhibit 78: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibit 79: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibit 80: Chart on France - Year-over-year growth 2022-2027 (%); Exhibit 81: Data Table on France - Year-over-year growth 2022-2027 (%); 9.5 Italy - Market size and forecast 2022-2027; Exhibit 82: Chart on Italy - Market size and forecast 2022-2027 ($ million); Exhibit 83: Data Table on Italy - Market size and forecast 2022-2027 ($ million); Exhibit 84: Chart on Italy - Year-over-year growth 2022-2027 (%); Exhibit 85: Data Table on Italy - Year-over-year growth 2022-2027 (%); 9.6 UK - Market size and forecast 2022-2027; Exhibit 86: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 87: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 88: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 89: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.7 Rest of Europe - Market size and forecast 2022-2027; Exhibit 90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million); Exhibit 91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million); Exhibit 92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibit 93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%); 9.8 Market opportunity By Geographical Landscape; Exhibit 94: Market opportunity By Geographical Landscape ($ million); Exhibit 95: Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 96: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 97: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 98: Overview on factors of disruption; 11.4 Industry risks; Exhibit 99: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 100: Vendors covered; 12.2 Market positioning of vendors; Exhibit 101: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 102: Abbott Laboratories - Overview; Exhibit 103: Abbott Laboratories - Business segments; Exhibit 104: Abbott Laboratories - Key news; Exhibit 105: Abbott Laboratories - Key offerings; Exhibit 106: Abbott Laboratories - Segment focus; 12.4 Becton Dickinson and Co.; Exhibit 107: Becton Dickinson and Co. - Overview; Exhibit 108: Becton Dickinson and Co. - Business segments; Exhibit 109: Becton Dickinson and Co. - Key news; Exhibit 110: Becton Dickinson and Co. - Key offerings; Exhibit 111: Becton Dickinson and Co. - Segment focus; 12.5 bioMerieux SA; Exhibit 112: bioMerieux SA - Overview; Exhibit 113: bioMerieux SA - Product / Service; Exhibit 114: bioMerieux SA - Key offerings; 12.6 Danaher Corp.; Exhibit 115: Danaher Corp. - Overview; Exhibit 116: Danaher Corp. - Business segments; Exhibit 117: Danaher Corp. - Key news; Exhibit 118: Danaher Corp. - Key offerings; Exhibit 119: Danaher Corp. - Segment focus; 12.7 F. Hoffmann La Roche Ltd.; Exhibit 120: F. Hoffmann La Roche Ltd. - Overview; Exhibit 121: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 122: F. Hoffmann La Roche Ltd. - Key news; Exhibit 123: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 124: F. Hoffmann La Roche Ltd. - Segment focus; 12.8 Fluxergy Inc.; Exhibit 125: Fluxergy Inc. - Overview; Exhibit 126: Fluxergy Inc. - Product / Service; Exhibit 127: Fluxergy Inc. - Key offerings; 12.9 Johnson and Johnson Services Inc.; Exhibit 128: Johnson and Johnson Services Inc. - Overview; Exhibit 129: Johnson and Johnson Services Inc. - Business segments; Exhibit 130: Johnson and Johnson Services Inc. - Key news; Exhibit 131: Johnson and Johnson Services Inc. - Key offerings; Exhibit 132: Johnson and Johnson Services Inc. - Segment focus; 12.10 LifeScan IP Holdings LLC; Exhibit 133: LifeScan IP Holdings LLC - Overview; Exhibit 134: LifeScan IP Holdings LLC - Product / Service; Exhibit 135: LifeScan IP Holdings LLC - Key offerings; 12.11 Nova Biomedical Corp.; Exhibit 136: Nova Biomedical Corp. - Overview; Exhibit 137: Nova Biomedical Corp. - Product / Service; Exhibit 138: Nova Biomedical Corp. - Key offerings; 12.12 PHC Holdings Corp.; Exhibit 139: PHC Holdings Corp. - Overview; Exhibit 140: PHC Holdings Corp. - Business segments; Exhibit 141: PHC Holdings Corp. - Key offerings; Exhibit 142: PHC Holdings Corp. - Segment focus; 12.13 Siemens AG; Exhibit 143: Siemens AG - Overview; Exhibit 144: Siemens AG - Business segments; Exhibit 145: Siemens AG - Key news; Exhibit 146: Siemens AG - Key offerings; Exhibit 147: Siemens AG - Segment focus; 12.14 Sinocare Inc.; Exhibit 148: Sinocare Inc. - Overview; Exhibit 149: Sinocare Inc. - Product / Service; Exhibit 150: Sinocare Inc. - Key news; Exhibit 151: Sinocare Inc. - Key offerings; 12.15 Sysmex Corp.; Exhibit 152: Sysmex Corp. - Overview; Exhibit 153: Sysmex Corp. - Business segments; Exhibit 154: Sysmex Corp. - Key offerings; Exhibit 155: Sysmex Corp. - Segment focus; 12.16 Thermo Fisher Scientific Inc.; Exhibit 156: Thermo Fisher Scientific Inc. - Overview; Exhibit 157: Thermo Fisher Scientific Inc. - Business segments; Exhibit 158: Thermo Fisher Scientific Inc. - Key news; Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Trinity Biotech Plc; Exhibit 161: Trinity Biotech Plc - Overview; Exhibit 162: Trinity Biotech Plc - Product / Service; Exhibit 163: Trinity Biotech Plc - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 164: Inclusions checklist; Exhibit 165: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 166: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 167: Research methodology; Exhibit 168: Validation techniques employed for market sizing; Exhibit 169: Information sources; 13.5 List of abbreviations; Exhibit 170: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Europe: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ million); Exhibits18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million); Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Five forces analysis - Comparison between 2022 and 2027; Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits25: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits26: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits27: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits28: Chart on Market condition - Five forces 2022 and 2027; Exhibits29: Chart on Type - Market share 2022-2027 (%); Exhibits30: Data Table on Type - Market share 2022-2027 (%); Exhibits31: Chart on Comparison by Type; Exhibits32: Data Table on Comparison by Type; Exhibits33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million); Exhibits34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million); Exhibits35: Chart on OTC testing - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%); Exhibits37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million); Exhibits38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million); Exhibits39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibits40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibits41: Market opportunity by Type ($ million); Exhibits42: Data Table on Market opportunity by Type ($ million); Exhibits43: Chart on Application - Market share 2022-2027 (%); Exhibits44: Data Table on Application - Market share 2022-2027 (%); Exhibits45: Chart on Comparison by Application; Exhibits46: Data Table on Comparison by Application; Exhibits47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million); Exhibits48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million); Exhibits49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million); Exhibits52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million); Exhibits53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibits55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million); Exhibits56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million); Exhibits57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibits58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibits59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million); Exhibits60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million); Exhibits61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibits62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibits63: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits64: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits65: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits66: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits67: Market opportunity by Application ($ million); Exhibits68: Data Table on Market opportunity by Application ($ million); Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits70: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibits71: Data Table on Market share By Geographical Landscape - 2022-2027 (%); Exhibits72: Chart on Geographic comparison; Exhibits73: Data Table on Geographic comparison; Exhibits74: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits75: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits76: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits77: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits78: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibits79: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibits80: Chart on France - Year-over-year growth 2022-2027 (%); Exhibits81: Data Table on France - Year-over-year growth 2022-2027 (%); Exhibits82: Chart on Italy - Market size and forecast 2022-2027 ($ million); Exhibits83: Data Table on Italy - Market size and forecast 2022-2027 ($ million); Exhibits84: Chart on Italy - Year-over-year growth 2022-2027 (%); Exhibits85: Data Table on Italy - Year-over-year growth 2022-2027 (%); Exhibits86: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits87: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits88: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits89: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million); Exhibits91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million); Exhibits92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibits93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibits94: Market opportunity By Geographical Landscape ($ million); Exhibits95: Data Table on Market opportunity By Geographical Landscape ($ million); Exhibits96: Impact of drivers and challenges in 2022 and 2027; Exhibits97: Overview on Criticality of inputs and Factors of differentiation; Exhibits98: Overview on factors of disruption; Exhibits99: Impact of key risks on business; Exhibits100: Vendors covered; Exhibits101: Matrix on vendor position and classification; Exhibits102: Abbott Laboratories - Overview; Exhibits103: Abbott Laboratories - Business segments; Exhibits104: Abbott Laboratories - Key news; Exhibits105: Abbott Laboratories - Key offerings; Exhibits106: Abbott Laboratories - Segment focus; Exhibits107: Becton Dickinson and Co. - Overview; Exhibits108: Becton Dickinson and Co. - Business segments; Exhibits109: Becton Dickinson and Co. - Key news; Exhibits110: Becton Dickinson and Co. - Key offerings; Exhibits111: Becton Dickinson and Co. - Segment focus; Exhibits112: bioMerieux SA - Overview; Exhibits113: bioMerieux SA - Product / Service; Exhibits114: bioMerieux SA - Key offerings; Exhibits115: Danaher Corp. - Overview; Exhibits116: Danaher Corp. - Business segments; Exhibits117: Danaher Corp. - Key news; Exhibits118: Danaher Corp. - Key offerings; Exhibits119: Danaher Corp. - Segment focus; Exhibits120: F. Hoffmann La Roche Ltd. - Overview; Exhibits121: F. Hoffmann La Roche Ltd. - Business segments; Exhibits122: F. Hoffmann La Roche Ltd. - Key news; Exhibits123: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits124: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits125: Fluxergy Inc. - Overview; Exhibits126: Fluxergy Inc. - Product / Service; Exhibits127: Fluxergy Inc. - Key offerings; Exhibits128: Johnson and Johnson Services Inc. - Overview; Exhibits129: Johnson and Johnson Services Inc. - Business segments; Exhibits130: Johnson and Johnson Services Inc. - Key news; Exhibits131: Johnson and Johnson Services Inc. - Key offerings; Exhibits132: Johnson and Johnson Services Inc. - Segment focus; Exhibits133: LifeScan IP Holdings LLC - Overview; Exhibits134: LifeScan IP Holdings LLC - Product / Service; Exhibits135: LifeScan IP Holdings LLC - Key offerings; Exhibits136: Nova Biomedical Corp. - Overview; Exhibits137: Nova Biomedical Corp. - Product / Service; Exhibits138: Nova Biomedical Corp. - Key offerings; Exhibits139: PHC Holdings Corp. - Overview; Exhibits140: PHC Holdings Corp. - Business segments; Exhibits141: PHC Holdings Corp. - Key offerings; Exhibits142: PHC Holdings Corp. - Segment focus; Exhibits143: Siemens AG - Overview; Exhibits144: Siemens AG - Business segments; Exhibits145: Siemens AG - Key news; Exhibits146: Siemens AG - Key offerings; Exhibits147: Siemens AG - Segment focus; Exhibits148: Sinocare Inc. - Overview; Exhibits149: Sinocare Inc. - Product / Service; Exhibits150: Sinocare Inc. - Key news; Exhibits151: Sinocare Inc. - Key offerings; Exhibits152: Sysmex Corp. - Overview; Exhibits153: Sysmex Corp. - Business segments; Exhibits154: Sysmex Corp. - Key offerings; Exhibits155: Sysmex Corp. - Segment focus; Exhibits156: Thermo Fisher Scientific Inc. - Overview; Exhibits157: Thermo Fisher Scientific Inc. - Business segments; Exhibits158: Thermo Fisher Scientific Inc. - Key news; Exhibits159: Thermo Fisher Scientific Inc. - Key offerings; Exhibits160: Thermo Fisher Scientific Inc. - Segment focus; Exhibits161: Trinity Biotech Plc - Overview; Exhibits162: Trinity Biotech Plc - Product / Service; Exhibits163: Trinity Biotech Plc - Key offerings; Exhibits164: Inclusions checklist; Exhibits165: Exclusions checklist; Exhibits166: Currency conversion rates for US$; Exhibits167: Research methodology; Exhibits168: Validation techniques employed for market sizing; Exhibits169: Information sources; Exhibits170: List of abbreviations